Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell LymphomaJoshua P. Plotnik(AbbVie (United States)), William N. Pappano(AbbVie (United States))Molecular Cancer TherapeuticsMarch 20, 202410.1158/1535-7163.mct-23-0518Cited by 6SaveCiteExport RISWatch citationsRelated PapersThe Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia|PLoS ONE|2015|94Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells|BMC Cancer|2014|28